Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jill M. Quigley Insider Profile
4 Followers
Jill M. Quigley, COO at Passage Bio, holds 0.00 shares in Terns Pharmaceuticals (Ticker: TERN), holds 372.36K shares in Passage Bio (Ticker: PASG), holds ― shares in Chemomab Therapeutics (Ticker: CMMB).
Profitable Transactions
2 out of 3 Profitable Transactions
Average Return
+14.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Jill M. Quigley holds in companies
Most Profitable Insider Trade
The most profitable trade made by Jill M. Quigley
Jill M. Quigley's Trading History
Passage Bio
Dec 10, 2021
COO
Uninformative Buy
16.55K
$223.42K
Terns Pharmaceuticals
Jan 06, 2025
Director
Uninformative Sell
50.72K
$0.00
Chemomab Therapeutics
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Jill M. Quigley's performance on stock
You May Also Like
Jill M. Quigley insider profile FAQ
What is the percentage of profitable transactions made by Jill M. Quigley?
The percentage of profitable transactions made by Jill M. Quigley is 67%.
What is the average return per transaction made by Jill M. Quigley?
The average return per transaction made by Jill M. Quigley is 14.40%.
What stocks does Jill M. Quigley hold?
Jill M. Quigley holds: PASG, TERN, CMMB stocks.
What was Jill M. Quigley’s latest transaction?
Jill M. Quigley latest transaction was an Uninformative Sell of $50.72K.
What was Jill M. Quigley's most profitable transaction?
Jill M. Quigley’s most profitable transaction was an Informative Sell of TERN stock on August 5, 2024. The return on the trade was 31.40%.
What is Jill M. Quigley's role in Passage Bio?
Jill M. Quigley's role in Passage Bio is COO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.